Literature DB >> 1902636

Acute lung injury induced by phospholipase A2. Structural and functional changes.

J D Edelson1, P Vadas, J Villar, J B Mullen, W Pruzanski.   

Abstract

On the basis of the observation that serum levels of phospholipase A2 (PLA2) are elevated in pancreatitis and systemic sepsis, and the association of these conditions with the subsequent development of acute lung injury, the present investigation examined the structural and physiologic consequences of intratracheal administration of PLA2 to adult male rats. Rats received direct intratracheal instillation of either control vehicle or 40,000 units/kg of PLA2 repurified from Naja naja venom. Animals treated with PLA2 showed higher cumulative mortality (33% versus 0%, n = 79; p less than 0.01) than did their control littermates. The PLA2-treated animals showed histologic evidence of acute lung injury characterized by interstitial and alveolar edema, accumulation of inflammatory cells, and alveolar wall thickening, which reached maximal severity 48 h after enzyme instillation. Forty-eight hours after PLA2 administration experimental animals had lower arterial oxygen tensions (73.9 +/- 7.66 mm Hg versus 96.7 +/- 2.52 mm Hg, mean +/- SEM; p less than 0.01), higher alveolar-arterial oxygen gradients (35.3 +/- 6.3 mm Hg versus 18.8 +/- 1.42 mm Hg, p less than 0.01), and higher wet-dry lung weight ratios (5.08 +/- 0.26, mean +/- SEM, n = 7 versus 3.29 +/- 0.08, n = 3; p less than 0.002) than did control animals. Lung lavage from experimental animals 48 h after PLA2 instillation showed increased total cell counts [(26.6 +/- 5.04) x 10(6) cells versus (4.69 +/- 1.48) x 10(6) cells; p less than 0.01], an increased percentage of neutrophils (34.2 +/- 4.6% versus 1.25 +/- 0.25%, mean +/- SEM; p less than 0.01), and increased protein concentrations in lavage fluid (0.38 +/- 0.06 mg/ml, mean +/- SEM, n = 4 versus 0.27 +/- 0.02 mg/ml, n = 5; p less than 0.05). The histologic and physiologic abnormalities had largely resolved by 240 h. These results suggest that PLA2 may be a potent mediator of lung inflammation and that intratracheal administration of PLA2 to adult rats may provide a useful experimental model of acute lung injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902636     DOI: 10.1164/ajrccm/143.5_Pt_1.1102

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  17 in total

1.  Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids.

Authors:  W Pruzanski; K Scott; G Smith; I Rajkovic; E Stefanski; P Vadas
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

2.  Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro.

Authors:  Steven M Dudek; Nilda M Muñoz; Anjali Desai; Christopher M Osan; Angelo Y Meliton; Alan R Leff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-06       Impact factor: 6.914

3.  Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2.

Authors:  B Guidet; O Piot; J Masliah; V Barakett; E Maury; G Bereziat; G Offenstadt
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

4.  Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.

Authors:  L Arbibe; K Koumanov; D Vial; C Rougeot; G Faure; N Havet; S Longacre; B B Vargaftig; G Béréziat; D R Voelker; C Wolf; L Touqui
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

5.  Phospholipase A2 mediates nitric oxide production by alveolar macrophages and acute lung injury in pancreatitis.

Authors:  Y Tsukahara; T Morisaki; Y Horita; M Torisu; M Tanaka
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

6.  Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma.

Authors:  J Sörensen; B Kald; C Tagesson; M Lindahl
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

7.  Genetic inactivation of the phospholipase A2 activity of peroxiredoxin 6 in mice protects against LPS-induced acute lung injury.

Authors:  José Pablo Vázquez-Medina; Jian-Quin Tao; Priyal Patel; Renata Bannitz-Fernandes; Chandra Dodia; Elena M Sorokina; Sheldon I Feinstein; Shampa Chatterjee; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-31       Impact factor: 5.464

8.  Purification of a 100 kDa phospholipase A2 from spleen, lung and kidney: antiserum raised to pig spleen phospholipase A2 recognizes a similar form in bovine lung, kidney and platelets, and immunoprecipitates phospholipase A2 activity.

Authors:  D K Kim; J V Bonventre
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

9.  Role of Kupffer cells in acute hemorrhagic necrotizing pancreatitis-associated lung injury of rats.

Authors:  Hong-Bin Liu; Nai-Qiang Cui; Dong-Hua Li; Chang Chen
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

10.  Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin.

Authors:  W Pruzanski; D W Wilmore; A Suffredini; G D Martich; A G Hoffman; J L Browning; E Stefanski; B Sternby; P Vadas
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.